News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Merck & Co., Inc. to Pay Over $650M to Settle US Drug Pricing Probe
February 7, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON (AFP) — Pharmaceutical giant Merck & Co. has agreed to pay over 650 million dollars to resolve allegations of fraudulent drug pricing and improper kickbacks, the US Justice Department announced Thursday.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Legal
Lilly cracks down on black market for obesity asset retatrutide with six lawsuits
August 12, 2026
·
2 min read
·
Tristan Manalac
Regulatory
Lilly, FDA retatrutide biologic dispute comes to a head as submission nears
August 5, 2026
·
3 min read
·
Annalee Armstrong
Legal
Novo ordered to face CagriSema fraud claims from shareholders: New Jersey court
July 29, 2026
·
2 min read
·
Tristan Manalac
China
US ‘eroding’ lead in rare diseases a matter of national security: Report
July 22, 2026
·
4 min read
·
Tristan Manalac
